Inhibitors of the n-terminal domain of the androgen receptor
US-2019382335-A1 · Dec 19, 2019 · US
US9708237B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9708237-B2 |
| Application number | US-201214344574-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 5, 2012 |
| Priority date | Sep 16, 2011 |
| Publication date | Jul 18, 2017 |
| Grant date | Jul 18, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a water-soluble fluorescent compound of resveratrone 6-O-β-glucoside [(E)-4-(8-hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)naphthalen-2-yl)but-3-en-2-one] and its derivatives of Formula 1 which have at least one water-soluble substituent, and a method for preparing the same by a photochemical reaction of resveratrol 3-O-β-glucoside and its derivatives of having Formula 3 which are not fluorescent. Said new water-soluble fluorescent compounds has single-photon absorptive characteristics and/or two-photon absorptive characteristics as well as no or little toxicity, and can be usefully utilized in fields that requires water-soluble fluorescent characteristics (diagnosis, fluorescent probe, in vivo imaging, display, etc.).
Opening claim text (preview).
What is claimed is: 1. A method of preparing a fluorescent compound comprising a compound represented by the following Formula 1, characterized in that it comprises a step of dissolving a compound represented by the following Formula 3 in water or an organic solvent, and a step of subjecting to an UV irradiation: wherein, R 1 and R 2 are independently selected from the group consisting of hydrogen atom; straight-chain or branched C1-C10 alkyl; C1-C10 alkylcarbonyl; C3-C6 cycloalkyl; C6-C30 aryl; and C5-C30 heteroaryl comprising: at least one heteroatom N, O or S; a residue of a water-soluble natural compound; a residue of a water-soluble polymer; or a residue of a water-soluble high molecular organic compound, provided that at least one of R 1 and R 2 represents a residue of a water-soluble natural compound, a residue of a water-soluble polymer or a residue of a water-soluble high molecular organic compound, said water-soluble natural compound, water-soluble polymer or water-soluble high molecular organic compound selected from a group consisting of monosaccharide, disaccharide, oligosaccharide, a water-soluble vitamin, polyethylene glycol, polypropylene glycol, PVA, crospovidone, PVP, and PVP-PVA, characterized in that ascorbic acid, polyphenol or mixture thereof is further added before the UV radiation, wherein the compound is fluorescent. 2. The method according to claim 1 , characterized in that it is conducted under N 2 atmosphere (N 2 purging).
having unsaturation outside the aromatic rings · CPC title
Condensed systems · CPC title
Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems · CPC title
containing organic luminescent materials · CPC title
Small organic molecules (oligomers, polymers, dendrimers A61K49/0054) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.